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The  dynamics  of  the  interaction  of serum protein  antigens  and  antibody 
during  a  rabbit's immune response have been studied  in  considerable detail, 
using I131-1abelled antigens  (1,  2).  These studies  indicate  that  as  antibody is 
formed by the host,  it combines with  circulating  antigen  and  these antigen- 
antibody complexes are removed from the  circulation,  more or less, rapidly. 
Following this elimination of the complexes, free antibody  appears in the cir- 
culation and la81-1abelled antigen is no longer detectable in the blood. However, 
a  series  of publications  has  reported  that  complexes of such  serum  protein 
antigens  (3,  4)  or antigen-like materials  (5,  6)  and  the homologous antibody 
may persist in the circulation of the rabbit long after the  appearance of free 
antibody. The present studies were undertaken to help resolve this difference, 
and also to obtain precise knowledge of the development of serum protein anti- 
gen-antibody complexes and  their fate in vivo. Knowledge concerning  the in 
vivo formation and fate of these complexes is particularly important since they 
have  been implicated  in  the  immunopathologic changes  associated  with  the 
injection  of such antigens  (7-9). 
Materials  and  Methods 
1131-Labeged Antigen.--Bovine serum albumin (BSA), Armour and Co., Lot P67908, was 
labelled with 1131 (I*) by the method described by Talmage et a2. (1). 
X-Radiation.--Some of the rabbits were given 400 r whole body x-radiation 48 hours prior 
to the injection of antigen. X-radiation was done at 200 kvp and 15 ma. with a filter of 1 ram. 
A1 and 0.25 ram. Ca delivering at a rate of 16 r per minute at the target distance. 
Injections and Bleedings.--Fifteen normal, and  7 x-radiated albino rabbits weighing ap- 
proximately 2.5 kg. were injected intravenously with 100 mg. of I*BSA and then bled (8 to 
15 ml. of blood), periodically. Seven of the normal rabbits were later given another intrave- 
nous injection of I*BSA (50 rag.) and again bled periodically. 
* Supported by the United States Atomic Energy Commission  Contract  No. AT (30-1)- 
1205. 
Publication  145 of the  Department  of Pathology, University of Pittsburgh  School of 
Medicine. 
§ Public Health Service Research Fellow of the National  Institute of Neurological Dis- 
cases and Blindness. 
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Analyzes of Sera.--The sera were separated from the blood and analyzed for I*BSA, anti- 
BSA, alkalioprecipitable material  (3), and I*BSA bound to globulin (antibody). 
The amount of I*BSA remaining in the blood of rabbits was determined by counting the 
protein-bound (precipitated with  10 per cent trichloroacetic acid) I* activity of the sera in 
well type gamma counters. Sufficient counts were obtained to insure a maximum counting 
error of no greater than 5 per cent. 
Anti-BSA was determined by the quantitative immunochemlcal technique developed by 
Heidelberger and coworkers (10). Before the sera were analyzed for antibody they were de- 
complemented with I00 nag. N per mL of an unrelated antigen--antibody precipitate  (11). 
It was possible to detect the presence of circulating I*BSA which was bound to globulin 
by employing the ammonium sulfate precipitation technique of Farr (12). The sera containing 
I*BSA were fractionated at SO per cent ammonium sulfate saturation at 0°C. This treatment 
precipitates the serum globulin plus any I*BSA which is combined with it. I*BSA not com- 
bined with the globulin remains in the supernatant. It is assumed that the I*BSA precipitated 
at 50 per cent ammonium sulfate saturation is bound to antibody  globulin and present in the 
sera in the form of soluble I*BSA-anti-BSA complexes. 
Sera were tested for alkali-precipitable material by the method described by Sternberger 
(3). Three ml. of the sera were diluted with an equal volume of 0.15 ~ NaC1 and adjusted to 
pH 12.5 at 1°C. with NaOH and allowed to remain at 1°C. for 6 minutes, and then readjusted 
with HC1 to the original pH. The readjusted sera were made up to 4 volumes with 0.15 
HaC1 and 1:10,000 merthiolate, and incubated for 2 hours at 37°C., and then stored for 4 to 
10 days at 0-3°C. The precipitates which formed were washed twice with 8 ml. of 0.15 
NaC1, dissolved in NaOH, and then made up to known volumes in volumetric flasks. Aliquots 
were then removed with volumetric pipettes for N analyses. The 1  lal content of alkali-precipi- 
table material, obtained from sera which also contained I*BSA, was determined before the 
precipitates were dissolved with NaOH. The ability of excess BSA to dissolve alkali-precipi- 
table material was tested. Precipitates obtained from 1 to 3 ml. of several of the sere were 
finely suspended and transferred to 5 ml. volumetric flasks. The suspensions were made up 
to volume and 1 ml. aliquots transferred, with volumetric pipettes, to 4 ml. conical centrifuge 
tubes. 2.4 nag. of BSA N were added to 2 of the tubes and an equal volume of 0.15 ~ NaC1 
was added to the other 2 tubes. The 0.15 ~ NaCI and the BSA solution were buffered at pH 
7.2, with phosphate buffer, and contained 1:10,000 merthiolate. After incubation at 37°C. 
for 1 hour, and then storage at 0 to 3°C. for 2 days, the precipitates were washed twice with 
2 ml. of 0.15 M  NaC1 and the total N was determined. The Markham modification of the micro 
KjeldaJal technique was used for all N  determinations  (13). 
RE$1YLTS 
Serological Changes Following Intravenous Injections of I*BSA into Rabbits.-- 
I*BSA  (100 rag.)  injected into  normal  rabbits,  after  equilibration between 
intra- and extravascular fluids, was eliminated at a slow logarithmic rate until 
the 7th to 9th day, when a  rapid immune elimination of the I*BSA began in 
most of the animals (Table  I). The maximum concentration  of antibody  appeared 
in 2 to 4 days after the disappearance of I*BSA from the blood. Similar results 
have been previously reported by Talmage et al. (1). In most of the animals a 
portion of the circulating I*BSA was bound to serum globulin at the same time 
that  immune elimination of  the  antigen began. The per  cent of  the I*BSA 
bound to globulin increased until the antigen was almost completely eliminated 
from the blood.  Several animals showed  decreases  in the per  cent of  the  I* TABLE I 
Serological Changes Following Intravenous Injections  of I*BSA  into Rabbits 
Days following first injection  of I*BSA (I00 nag.). 
Rabbit 
~o, 
46-70 
46-71 
46-72, 
46-73 
46-74 
46-75 
46-76 
47-67 
Max- 
inmm 
anti- 
body 
N* 
mg. 
198.9 
105.1 
57.2 
121,6 
200.4 
129.7 
249.8 
47-68 
47-69 
47-70 
47-71 
47-72 
47-73 
47-74 
*Maximum concentration of antibody was found in the sera 2 to 4 days after complete antigen elimination. 
Seven of the rabbits received a second injection of I*BSA (50 nag.) on the 17th day following the first in- 
jection. The blood analyzed on the 17th day was collected  2 hours foUowing the injection of I*BSA. 
A, per cent I*BSA injected remaining in total blood volume. 
B, per cent I*BSA remaining in total blood volume precipitabie with 50 per cent (NH4):SO~ saturation. 
C, rag. N  precipitated/ml, serum after treatment with alkali  (3). 
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bound to globulin when the circulating protein-bound I* fell below 0.3 per cent. 
This might have been the result of the persistence of trace amounts of contam- 
inating  I* serum proteins.  The I*BSA preparation  contained  approximately 
1 per cent of bovine proteins other than albumin and these trace contaminants 
may have remained  in  the circulation  after  the immune  elimination  of the 
albumin. 
Two hours after a second injection of I*BSA (50 nag.), 20 to 60 per cent of 
the  circulating  antigen  was bound to  serum globulin,  presumably antibody 
persisting  from the previous response. The fall in protein-bound I*BSA between 
2 hours and 2 days and the subsequent rise between the 2nd and 4th day was 
probably the  result of elimination  of the  complexes  formed with persisting 
antibody and then an increase  in complexes arising from the reaction of newly 
synthesized and-BSA with the remaining  I*BSA. 
Five of the 15 normal rabbits receiving a primary injection of I*BSA devel- 
oped alkali-precipitable material in their sera, which first appeared between the 
8th and 14th day following the injection. When 7 of these rabbits (2 of which 
had alkali-precipitable material after the first injection)  (Table I) were given 
a second injection of I*BSA, 17 days after the first, 3 additional animals devel- 
oped alkali-precipitable material in their sera. The alkali-precipitable material 
appeared in the sera of these 3 rabbits 4 to 6 days following the second injection 
of antigen.  One rabbit (No. 46-70) whose serum contained alkali-precipitable 
material after the first injection did not have this material in its serum after 
the second injection. There was no correlation between the presence or absence 
of  alkali-precipitable  material  and  the  m~imum  antibody  concentration. 
Seven rabbits receiving 400 r whole body-radiation 2 days prior to the injection 
of 100 rag.  of I*BSA and not showing an immune elimination of the antigen, 
contained  neither  circulating  I*BSA-anti-BSA  complexes  nor  alkali-pre- 
cipitable material in their sera. 
Fig.  1 is a graphic representation of serological changes following injections 
of I*BSA into a rabbit. Immune elimination  of the initial  injection of antigen 
began shortly after the 7th day and was completed by the llth day. It can be 
seen that  with the appearance of antigen-antibody complexes  in the serum, 
immune elimination began and that the per cent of circulating I*BSA bound to 
the globulin increased with time. Free anti-BSA was first observed in the serum 
shortly after the elimination  of circulating I*BSA. A second injection of I*BSA 
on the 17th day was followed by a rapid drop in circulating  antigen as a result 
of the simultaneous combination of I*BSA with persisting antibody and equili- 
bration of I*BSA between intra- and extravascular fluid spaces. Rapid immune 
elimination  of the remaining  I*BSA, beginning  between the 2nd and 4th day, 
was the result of newly synthesized antibody. Alkali-precipitable  material was 
present in the serum of this animal on the 14th and 16th day following the first 
injection but not after the second injection. The pattern of both antigen elimina- WILLIAM  O.  WEIGLE  657 
tion and  appearance  of circulating antigen-antibody complexes seen in  this 
animal is representative of most of the animals studied.  However, a  rabbit 
(No. 46-71) which eliminated the antigen more slowly, gave somewhat different 
results (Fig. 2). This rabbit did not eliminate the first injection of I*BSA until 
the 15th or 16th day, and circulating antigen-antibody complexes were detected 
over a 5 day period. The complexes appeared in the serum by the 9th day, before 
the immune elimination of I*BSA was initiated, and on the 12th day almost all 
of the circulating I*BSA was bound to globulin. Alkali-precipitable material 
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was detected in large amounts during the immune elimination of antigen. This 
material was also detected in the serum after the second injection of antigen, 
reaching a  peak on the 6th day and disappearing by the llth day after the 
injection. 
One  would  not  necessarily  expect  the  complexes,  precipitated  with 
ammonium sulfate at 0°C., to be representative of the complexes as they circu- 
late in the blood at 37°C.  In order to obtain a more authentic picture of the 
complexes as they do exist in rivo,  the complexes in some of the sera were also 
precipitated  by ammonium sulfate at 37°C.  (Fig.  3).  Somewhat less  of the 
I*BSA was combined with globulin at 37°C. than at 0°C. This was probably the 
result of a greater dissociation of complexes at the higher temperature. bJ 
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Circulating I*BSA  Precipitated by Alkali and Ammonium Sulfale.--Four  of 
the 15 normal animals, injected for the first time with I*BSA, contained both 
alkali-precipitable material and I*BSA in their sera at the same time. In order 
TABLE II 
Circulating I*BSA Pre¢ipitated  by Alkali and Ammonium Sulfate 
Rabbit No. 
46-71 
46-71 
46-71 
46-71 
46-71 
46-71 
47-73 
47-73 
47-74 
47-74 
46-75 
Day following 
1st injection of 
I*BSA$ 
9 
10 
12 
14 
17§ 
19 
8 
10 
8 
10 
21 
Protein pptd, by alkali treatment  Percentage circulating I*BSA 
pptd. by 
Alkali  Ammonium 
sulfate 
0  16.5 
0.7  47.5 
2.1  96.2 
2.9  86.7 
2.3  51.0 
1.9  40.1 
0.6  15.8 
0.2  40.1 
0.8  35.6 
0.4  91.0 
1.8  40.2 
Total N/ml.  BSA N/ml. 
sera /.~g.  sera pg. 
15.5  0 
219  0.48 
429  0.27 
658  0.09 
530  3.15 
296  1.56 
168  0.62 
30.4  0.11 
244  0.50 
39.4  0.02 
616  0.05 
treatment 
~: The second injection of I*BSA was given on the 17th day. 
§ This bleeding was made 2 hours after the second injection of I*BSA. 
TABLE IX[ 
Effect of Antigen on the Solubility of Alkali-Precipitable Material 
Rabbit No. 
47-71 
47-71 
46-75 
47-73 
47-74 
Day following first 
injection of I*BSA 
12 
235 
25 
8 
8 
Total N  remaining in alklali ppts. 
After incubation* 
with 0.15 u  NaCI 
172 
162 
159 
126 
118 
After incubation* 
with 2.8 mg. BSA N 
164 
176 
142 
113 
129 
* Precipitates  were incubated  at 37°C. for 1 hour and then at 0-3°C. for 48 hours. 
injection of I  BSA was  on  The second  *  given  the 17th day. 
to  determine whether  the  alkalioprecipitable material contained I*BSA,  the 
precipitates resulting from alkali treatment were washed with 0.15 M NaCI and 
their I* activity determined. The amount of  I*BSA as  determined from I* 
radioactivity is shown in Table IL Only a very small per cent of the circulating 660  ANTIGEN-ANTIBODY  COMPI~XES 
I*BSA was present in the alkali-precipitable  material even when a large per 
cent of it was bound to serum globulin as determined by ammonium sulfate 
precipitation. The/zg. of I*BSA N which was precipitable  by alkali treatment 
was extremely small in comparison to the total/zg, of N  precipitated. If one 
assumes  for the  moment that  the  alkali-precipitable  material was  antigen- 
antibody complexes as has been reported,  and calculates antibody N/antigen 
N ratios from the above values, one arrives at ratios between 150 and 10,000, 
which are in complete disagreement with the known properties of I*BSA-anti- 
BSA precipitates. 
DissolvAion of Alkali-Precipitable Material with Excess Antigen.--The alkali- 
precipitable  material from five sera of 4 different rabbits was incubated both in 
the presence and in the absence of BSA. The amount of N  remaining in the 
precipitates was approximately the same in both instances (Table  III). Under 
the conditions of the experiment and with the concentration of BSA employed, 
it appeared  that excess antigen was not able to dissolve the alkali-precipitable 
material. 
DISCUSSION 
It has been  postulated that once  antibody to a  serum  protein-antigen is 
synthesized it combines with the antigen in the blood, and the resulting com- 
plex is then rapidly removed from the circulation (i). In the present experiments 
a rapid immune elimination of the antigen began,  in most of the rabbits, at 
about the same time that antigen-antibody  complexes appeared in the sera. The 
immune elimination of antigen from the blood of most rabbits, presumably in 
the form of complexes, takes only a few days. However, complexes were present 
in the sera of one rabbit (No. 46-71), I  to 2 days prior to the rapid immune 
elimination of the antigen. It seems likely that once antibody is synthesized it 
attaches to antigen, forming antigen-antib0dy complexes in the body fluids. 
Early in antibody formation these  complexes are formed in conditions  of 
great antigen excess and as has been reported elsewhere, such complexes can 
circulate  for some time in the blood  (14). As more  antibody is synthesized, 
the antibody/antigen ratio of the complexes increases, thus increasing the size 
of the complexes until they are rapidly removed from the circulation.  If this is 
the case, then the rate of antibody synthesis,  the amount of antigen injected, 
and perhaps  the quality of antibody produced  would  determine the rate of 
immune elimination of  antigen.  Complement may also  affect  the  immune 
elimination  of antigen since it is capable of both reacting with and precipitating 
soluble  protein-rabbit  antiprotein complexes in  vitro (15). The  sequence  of 
complex formation and antigen elimination in rabbits injected with I00 rag. of 
I*BSA is similar to that seen in guinea pigs injected with 3 to 4 rag. of I* rabbit 
serum albumin, although both events take place somewhat earlier in rabbits (16). 
There is little relationship between the alkali-precipitable  material described w~L~  o.  vc~m~.  661 
by  Sternberger  (6)  and  the  I*  antigen-antibody complexes precipitated  by 
ammonium sulfate. The ability of excess specific antigen to dissolve the alkali- 
precipitable material was used as evidence that this material consisted of antigen 
and specific antibody (5). In the present study, it was not possible to dissolve 
the alkali-precipitable material from 4 different sera with excess antigen. The 
amount of excess antigen used was at least 10 times that necessary to completely 
dissolve the same amount of immune precipitates which were prepared from 
BSA and rabbit anti-BSA. However, Sternberger et al. reported dissolution of 
alkali-precipitable material when much larger amounts of excess antigen were 
employed (4). At times, when both alkali-precipitable material and I*BSA were 
present in sera, significant quantities of the  I*BSA were never found in the 
alkali-precipitable material, although a large per cent of the I*BSA was bound 
to serum globulin. 
Sternberger  and  Dixon  have  observed  a  great  discrepancy  between  the 
amounts of I*-labelled bovine gamma globulin (I*BGG) and alkali-precipitable 
material in the circulation of immunized rabbits (17). Between 4 and 21  days 
after the immune elimination of I*BGG, I TM equivalent to 0.04  #g. of I*BGG 
persisted per ml. of sera. In these same sera an average of 150/~g.  of alkali- 
precipitable N per ml. of sera was detected. If this alkali-precipitable material 
had been antibody-antigen complexes, the antibody N/antigen N  ratio would 
have been 3750 or more, which is obviously impossible. Whether this material 
contains a  host-synthesized antigen-like substance,  rather  than the original 
antigen, as has been recently suggested (6), remains to be seen. Thus, the in 
vivo work with I*-labelled antigen would seem to eliminate the possibility that 
alkali-precipitable material is an antigen-antibody complex. 
More recently it was proposed that in the alkali-precipitable material, the 
antigen-like material was bound,  in  the host,  to non-precipitating antibody 
rather than to precipitating antibody and that these complexes were capable 
of circulating in the host (6).  However, when protein-(non-precipitating)anti- 
protein complexes were prepared  at equivalence, in  ritro,  and injected intra- 
venously into rabbits, the complexes were immediately removed from the sera 
and did not return (14).  On the other hand, these complexes, prepared  in  a 
large excess of antigen, circulated in the blood with a half-life of approximately 
2 to 3 days, just as do complexes prepared with precipitating antibody and a 
large  amount  of  excess  antigen.  It  then  appears  that  antigen-(non-pre- 
cipitating)antibody complexes formed in vitro are handled in vivo in the same 
manner as antigen-(precipitating)antibody complexes. 
It was further suggested that the reaction of antigen-like material with non- 
precipitating antibody protects the material against elimination from the circula- 
tion and destruction by the host (6).  This protection was postulated as being 
the factor which permits the persistence of antigenic material, and, thus, the 
continued formation of antibody. However,  when protein-anti-protein corn- 662  ANTIGEN-ANTIBODY  COM_PLEXE  S 
plexes  (containing  either  precipitating  or  non-precipitating  antibody)  were 
injected  into  rabbits,  these  complexes  were  eliminated  from  the  circulation 
and catabolized more rapidly than either the antibody or antigen when injected 
alone (14). Also, native foreign serum proteins, which are capable of stimulating 
antibody production  in  the rabbit,  have never been demonstrated  to persist 
in that species for long periods of time. A number of workers have demonstrated 
that chemically modified proteins will persist in the rabbit, but these proteins 
have been shown to behave much differently in rabbits than the corresponding 
native  proteins  (18).  Furthermore,  Dixon  eta/.  (19)  and  more  recently 
McMaster  and  Edwards  (20)  have shown that  if there  is any persistence  of 
native protein antigens or their derivatives in the rabbit, they are not capable 
of eliciting significant antibody production in that species. 
S~ARY 
The immune elimination of soluble BSA, following an intravenous injection, 
is accompanied by the appearance of circulating  antigen-antibody  complexes. 
The pattern  of the appearance of circulating  antigen-antibody complexes and 
the immune elimination of antigen probably depends on the amount of antigen 
injected, the rate of antibody synthesis, and perhaps,  the quality of antibody 
produced. 
There is no relationship between the I* antigen-antibody complexes detected 
during the immune response in rabbits by ammonium sulfate precipitation and 
the material precipitated from immune sera as a result of treatment with alkali. 
Alkali-precipitable material present in the serum of rabbits at a time when I* 
antigen is also present contain at most only traces of the antigen. 
The author  wishes to acknowledge the excellent technical assistance  of  Miss  Dorothea 
Williamson and Mrs. Mary Bloom. 
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